|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
3/27/2013
|
Baker Mark Robert
|
CEO
|
50
|
$5.34
|
0.03%
|
|
3/27/2013
|
Baker Mark Robert
|
CEO
|
500
|
$5.31
|
0.31%
|
|
3/27/2013
|
Baker Mark Robert
|
CEO
|
100
|
$5.36
|
0.06%
|
|
3/22/2013
|
SCHEINBERG DAVID A
|
Director
|
1,250
|
$2.47
|
2.71%
|
|
3/22/2013
|
SCHEINBERG DAVID A
|
Director
|
-1,250
|
$4.81
|
-2.64%
|
|
2/27/2013
|
Baker Mark Robert
|
CEO
|
500
|
$2.71
|
0.31%
|
|
2/27/2013
|
Baker Mark Robert
|
CEO
|
535
|
$2.72
|
0.33%
|
|
2/27/2013
|
Baker Mark Robert
|
CEO
|
227
|
$2.75
|
0.14%
|
|
1/22/2013
|
Baker Mark Robert
|
CEO
|
900
|
$2.82
|
0.57%
|
|
1/22/2013
|
Baker Mark Robert
|
CEO
|
315
|
$2.83
|
0.20%
|
|
12/26/2012
|
Baker Mark Robert
|
CEO
|
1,142
|
$3.01
|
0.73%
|
|
11/28/2012
|
Baker Mark Robert
|
CEO
|
100
|
$2.12
|
0.06%
|
|
11/28/2012
|
Baker Mark Robert
|
CEO
|
100
|
$2.13
|
0.06%
|
|
11/28/2012
|
Baker Mark Robert
|
CEO
|
100
|
$2.13
|
0.06%
|
|
11/28/2012
|
Baker Mark Robert
|
CEO
|
1,000
|
$2.13
|
0.64%
|
|
11/28/2012
|
Baker Mark Robert
|
CEO
|
300
|
$2.12
|
0.19%
|
|
11/19/2012
|
Baker Mark Robert
|
CEO
|
11,800
|
$1.96
|
8.23%
|
|
11/16/2012
|
Baker Mark Robert
|
CEO
|
49,793
|
$1.82
|
53.16%
|
|
11/15/2012
|
Baker Mark Robert
|
CEO
|
48,833
|
$1.69
|
108.91%
|
|
10/24/2012
|
Baker Mark Robert
|
CEO
|
1,162
|
$2.96
|
2.66%
|
|
9/26/2012
|
Baker Mark Robert
|
CEO
|
1,036
|
$3.32
|
2.43%
|
|
8/22/2012
|
Baker Mark Robert
|
CEO
|
815
|
$4.23
|
1.95%
|
|
7/25/2012
|
Baker Mark Robert
|
CEO
|
346
|
$10.04
|
0.83%
|
|
7/2/2012
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
1,000
|
$5.33
|
2.85%
|
|
7/2/2012
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
-1,000
|
$9.79
|
-2.77%
|
|
6/27/2012
|
Baker Mark Robert
|
CEO
|
100
|
$9.29
|
0.24%
|
|
6/27/2012
|
Baker Mark Robert
|
CEO
|
21
|
$9.27
|
0.05%
|
|
6/27/2012
|
Baker Mark Robert
|
CEO
|
179
|
$9.29
|
0.43%
|
|
6/27/2012
|
Baker Mark Robert
|
CEO
|
75
|
$9.21
|
0.18%
|
|
6/20/2012
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
-3,333
|
$8.58
|
-8.68%
|
|
6/20/2012
|
Olson William C
|
Senior VP, Research and Develo
|
-1,230
|
$8.69
|
-2.63%
|
|
6/1/2012
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
-1,000
|
$8.51
|
-2.54%
|
|
6/1/2012
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
1,000
|
$5.33
|
2.61%
|
|
5/23/2012
|
Baker Mark Robert
|
CEO
|
445
|
$7.81
|
1.09%
|
|
5/1/2012
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
-1,000
|
$10.93
|
-2.54%
|
|
5/1/2012
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
1,000
|
$5.33
|
2.61%
|
|
4/25/2012
|
Baker Mark Robert
|
CEO
|
133
|
$10.25
|
0.33%
|
|
4/25/2012
|
Baker Mark Robert
|
CEO
|
100
|
$9.92
|
0.25%
|
|
4/25/2012
|
Baker Mark Robert
|
CEO
|
15
|
$10.25
|
0.04%
|
|
4/25/2012
|
Baker Mark Robert
|
CEO
|
100
|
$9.97
|
0.25%
|
|
4/2/2012
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
-1,000
|
$9.85
|
-2.54%
|
|
4/2/2012
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
1,000
|
$5.33
|
2.61%
|
|
3/28/2012
|
Baker Mark Robert
|
CEO
|
140
|
$10.19
|
0.35%
|
|
3/28/2012
|
Baker Mark Robert
|
CEO
|
100
|
$10.00
|
0.25%
|
|
3/28/2012
|
Baker Mark Robert
|
CEO
|
103
|
$10.18
|
0.26%
|
|
3/1/2012
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
-1,000
|
$9.82
|
-2.54%
|
|
3/1/2012
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
1,000
|
$5.33
|
2.61%
|
|
2/23/2012
|
SCHEINBERG DAVID A
|
Director
|
-1,250
|
$10.00
|
-2.64%
|
|
2/23/2012
|
SCHEINBERG DAVID A
|
Director
|
1,250
|
$6.90
|
2.71%
|
|
2/22/2012
|
Baker Mark Robert
|
CEO
|
100
|
$9.40
|
0.25%
|
|
2/22/2012
|
Baker Mark Robert
|
CEO
|
166
|
$9.40
|
0.42%
|
|
2/22/2012
|
Baker Mark Robert
|
CEO
|
100
|
$9.45
|
0.25%
|
|
2/22/2012
|
Baker Mark Robert
|
CEO
|
2
|
$9.42
|
0.01%
|
|
2/3/2012
|
BRINER KURT W
|
Director
|
-33,000
|
$10.22
|
-100.00%
|
|
2/1/2012
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
1,000
|
$5.33
|
2.61%
|
|
2/1/2012
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
-1,000
|
$9.48
|
-2.54%
|
|
1/25/2012
|
Baker Mark Robert
|
CEO
|
100
|
$9.56
|
0.25%
|
|
1/25/2012
|
Baker Mark Robert
|
CEO
|
4
|
$9.50
|
0.01%
|
|
1/25/2012
|
Baker Mark Robert
|
CEO
|
3
|
$9.49
|
0.01%
|
|
1/25/2012
|
Baker Mark Robert
|
CEO
|
63
|
$9.45
|
0.16%
|
|
1/25/2012
|
Baker Mark Robert
|
CEO
|
193
|
$9.55
|
0.49%
|
|
1/11/2012
|
Baker Mark Robert
|
CEO
|
200
|
$8.87
|
0.51%
|
|
1/11/2012
|
Baker Mark Robert
|
CEO
|
191
|
$8.86
|
0.49%
|
|
1/3/2012
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
-1,000
|
$8.78
|
-2.54%
|
|
1/3/2012
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
1,000
|
$5.33
|
2.61%
|
|
12/1/2011
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
1,000
|
$5.33
|
2.61%
|
|
12/1/2011
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
-1,000
|
$6.66
|
-2.54%
|
|
11/23/2011
|
Baker Mark Robert
|
CEO
|
634
|
$5.45
|
1.68%
|
|
11/1/2011
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
-1,000
|
$6.33
|
-2.54%
|
|
11/1/2011
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
1,000
|
$5.33
|
2.61%
|
|
10/26/2011
|
Baker Mark Robert
|
CEO
|
76
|
$6.50
|
0.20%
|
|
10/26/2011
|
Baker Mark Robert
|
CEO
|
455
|
$6.52
|
1.21%
|
|
10/5/2011
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
1,000
|
$5.33
|
2.61%
|
|
10/5/2011
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
-1,000
|
$6.33
|
-2.54%
|
|
10/3/2011
|
MCKINNEY ROBERT A
|
Senior VP, CFO
|
-2,475
|
$5.44
|
-5.28%
|
|
10/3/2011
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
-3,290
|
$5.44
|
-7.89%
|
|
10/3/2011
|
Olson William C
|
Senior VP, Research and Develo
|
2,605
|
$4.62
|
5.60%
|
|
10/3/2011
|
Olson William C
|
Senior VP, Research and Develo
|
-2,356
|
$5.44
|
-4.80%
|
|
10/3/2011
|
MCKINNEY ROBERT A
|
Senior VP, CFO
|
2,737
|
$4.62
|
6.20%
|
|
10/3/2011
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
3,638
|
$4.62
|
9.56%
|
|
10/3/2011
|
Baker Mark Robert
|
CEO
|
-4,666
|
$5.44
|
-11.02%
|
|
10/3/2011
|
Baker Mark Robert
|
CEO
|
5,124
|
$4.62
|
13.77%
|
|
9/28/2011
|
Baker Mark Robert
|
CEO
|
527
|
$6.39
|
1.44%
|
|
9/28/2011
|
Baker Mark Robert
|
CEO
|
15
|
$6.38
|
0.04%
|
|
9/27/2011
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
-746
|
$6.33
|
-1.93%
|
|
9/27/2011
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
746
|
$5.33
|
1.97%
|
|
9/20/2011
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
-100
|
$6.33
|
-0.26%
|
|
9/20/2011
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
100
|
$5.33
|
0.26%
|
|
9/1/2011
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
-154
|
$6.33
|
-0.41%
|
|
9/1/2011
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
154
|
$5.33
|
0.41%
|
|
8/24/2011
|
Baker Mark Robert
|
CEO
|
571
|
$6.08
|
1.59%
|
|
8/11/2011
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
1,000
|
$5.33
|
2.64%
|
|
8/11/2011
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
-1,000
|
$6.33
|
-2.57%
|
|
7/27/2011
|
Baker Mark Robert
|
CEO
|
567
|
$6.12
|
1.60%
|
|
7/1/2011
|
Olson William C
|
Senior VP, Research and Develo
|
-5,276
|
$7.40
|
-10.22%
|
|
7/1/2011
|
MCKINNEY ROBERT A
|
Senior VP, CFO
|
-6,062
|
$7.40
|
-12.12%
|
|
7/1/2011
|
MCKINNEY ROBERT A
|
Senior VP, CFO
|
7,279
|
$5.46
|
17.03%
|
|
7/1/2011
|
Olson William C
|
Senior VP, Research and Develo
|
6,335
|
$5.46
|
13.99%
|
|
7/1/2011
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
1,000
|
$5.33
|
2.77%
|
|
7/1/2011
|
ISRAEL ROBERT J
|
Senior VP Medical Affairs
|
-1,000
|
$7.21
|
-2.69%
|